Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Grant/Award of 13,562 AVBP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 13,562 | n/a |
| Jul 3, 2025 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 7,500 | n/a |
| Jun 20, 2025 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 15,502 | n/a |
| Jun 10, 2024 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 7,500 | n/a |
| May 3, 2024 | Revance Therapeutics, Inc. (RVNC) | Grant/Award | 15,000 | n/a |
| Jan 29, 2024 | ArriVent Biopharma, Inc. (AVBP) | Grant/Award | 17,884 | n/a |
| Jun 8, 2023 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 47,000 | n/a |
| Oct 14, 2022 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 32,500 | n/a |
| Mar 23, 2022 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 78,045 | n/a |